Search - tctmd.com

Displaying 41 - 60 of 92

Sort: Relevancy | Date

Presentation TCT 2014

The Data Strongly Support Heparin!

Presenter: Stefanie Schüpke

September 14, 2014

Presentation TCT 2014

The Data Strongly Support Bivalirudin!

Presenter: Roxana Mehran

September 14, 2014

Presentation TCT 2014

EUROMAX STR: ST-Segment Resolution Analysis in Patients with ST-Segment Elevation Myocardial Infarction Randomized to Prehospital Bivalirudin Versus Heparin Plus a Routine Glycoprotein IIb/IIIa Inhibitor Prior to Primary Percutaneous Coronary Intervention

Presenter: Patrick W. Serruys, Jurrien M. Ten Berg

September 13, 2014

Presentation

Bivalirudin vs Heparin in Patients Planned for PCI

Presenter: Matthew A. Cavender

August 20, 2014

$Unfractionated Heparin vs Bivalirudin in Primary PCI: An Open-label, Single-Center, Randomized Trial$

Presentation

Unfractionated Heparin vs Bivalirudin in Primary PCI: An Open-label, Single-Center, Randomized Trial

Presenter: A. Shahzad

July 10, 2014

$Routine bivalirudin is superior to unfractionated heparin + bailout GP IIb/IIIa inhibitors in patients with STEMI transported for primary PCI: A prespecified subgroup analysis of the EUROMAX trial$

Presentation EuroPCR 2014

Routine bivalirudin is superior to unfractionated heparin + bailout GP IIb/IIIa inhibitors in patients with STEMI transported for primary PCI: A prespecified subgroup analysis of the EUROMAX trial

Presenter: Uwe Zeymer

May 21, 2014

Presentation

Prasugrel plus Bivalirudin vs Clopidogrel plus Heparin in Patients with STEMI

Presenter: Stefanie Schulz

May 14, 2014

Presentation

Heparin Monotherapy or Bivalirudin During PCI in NSTE-ACS or Stable Ischemic Heart Disease

Presenter: Sripal Bangalore

April 22, 2014

Presentation

Impact of Major Bleeding on Long-term Mortality in Anemic Patients Undergoing PCI Using Bivalirudin

Presenter: Ziad A. Ali

February 25, 2014

Presentation

Bivalirudin Or Heparin In Primary Angioplasty Performed Through The Transradial Approach

Presenter: Alessandro Sciahbasi

January 12, 2014

Presentation

Impact of Worsening Renal Dysfunction on the Comparative Efficacy of Bivalirudin and Platelet GPIs

Presenter: E. Perdoncin

December 10, 2013

Presentation TCT 2013

Transfemoral Access (Plus Bivalirudin and Vascular Closure Devices) Provides Optimal Results!

Presenter: Sorin Brener

October 31, 2013

Presentation TCT 2013

I'm Not So Sure: Bivalirudin Plus a Potent Oral ADP Antagonist Is All You Need!

Presenter: Frederick Feit

October 31, 2013

Presentation TCT 2013

EURO MAXX: Perspectives on Bivalirudin in STEMI

Presenter: E. Magnus Ohman

October 31, 2013

Presentation TCT 2013

Upstream Bivalirudin: Insights from EuroMax

Presenter: Philippe Gabriel Steg

October 30, 2013

Presentation TCT 2013

Featured Trial of the Day: EUROMAX: A Prospective, Randomized Trial of Ambulance Initiation of Bivalirudin vs. Heparin ± Glycoprotein IIb/IIIa Inhibitors in Patients with STEMI...

Presenter: Philippe Gabriel Steg

October 30, 2013

Presentation TCT 2013

TCT-55. Outcomes of Transfemoral Bivalirudin are Equivalent to Transradial PCI. “Old Dogs Don't Need to Learn New Tricks”

Presenter: Sundeep Adusumalli

October 29, 2013

Presentation TCT 2013

Anticoagulation and Antiplatelet Regimens After TAVR: Bivalirudin (BRAVO 2/3 Trial) and Other Alternatives

Presenter: George Dangas

October 28, 2013

Presentation

HORIZONS-AMI: Reduction in Cardiac Mortality with Bivalirudin in Patients With and Without Major Bleeding

Presenter: Gregg W. Stone

October 16, 2013

Presentation

Comparison of Bivalirudin and Radial Access Across a Spectrum of Pre-PCI Bleeding Risk

Presenter: 222684|Dmitri Baklanov

August 09, 2013

Advertisement

The Data Strongly Support Heparin!

The Data Strongly Support Bivalirudin!

EUROMAX STR: ST-Segment Resolution Analysis in Patients with ST-Segment Elevation Myocardial Infarction Randomized to Prehospital Bivalirudin Versus Heparin Plus a Routine Glycoprotein IIb/IIIa Inhibitor Prior to Primary Percutaneous Coronary Intervention

Bivalirudin vs Heparin in Patients Planned for PCI

Unfractionated Heparin vs Bivalirudin in Primary PCI: An Open-label, Single-Center, Randomized Trial

Routine bivalirudin is superior to unfractionated heparin + bailout GP IIb/IIIa inhibitors in patients with STEMI transported for primary PCI: A prespecified subgroup analysis of the EUROMAX trial

Prasugrel plus Bivalirudin vs Clopidogrel plus Heparin in Patients with STEMI

Heparin Monotherapy or Bivalirudin During PCI in NSTE-ACS or Stable Ischemic Heart Disease

Impact of Major Bleeding on Long-term Mortality in Anemic Patients Undergoing PCI Using Bivalirudin

Bivalirudin Or Heparin In Primary Angioplasty Performed Through The Transradial Approach

Impact of Worsening Renal Dysfunction on the Comparative Efficacy of Bivalirudin and Platelet GPIs

Transfemoral Access (Plus Bivalirudin and Vascular Closure Devices) Provides Optimal Results!

I'm Not So Sure: Bivalirudin Plus a Potent Oral ADP Antagonist Is All You Need!

EURO MAXX: Perspectives on Bivalirudin in STEMI

Upstream Bivalirudin: Insights from EuroMax

Featured Trial of the Day: EUROMAX: A Prospective, Randomized Trial of Ambulance Initiation of Bivalirudin vs. Heparin ± Glycoprotein IIb/IIIa Inhibitors in Patients with STEMI...

TCT-55. Outcomes of Transfemoral Bivalirudin are Equivalent to Transradial PCI. “Old Dogs Don't Need to Learn New Tricks”

Anticoagulation and Antiplatelet Regimens After TAVR: Bivalirudin (BRAVO 2/3 Trial) and Other Alternatives

HORIZONS-AMI: Reduction in Cardiac Mortality with Bivalirudin in Patients With and Without Major Bleeding

Comparison of Bivalirudin and Radial Access Across a Spectrum of Pre-PCI Bleeding Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content